Literature DB >> 22367604

White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome.

Efrosini Z Papadaki1, Vasileios C Mastorodemos, Emmanouil Z Amanakis, Konstantinos C Tsekouras, Antonis E Papadakis, Nikolaos D Tsavalas, Panagiotis G Simos, Apostolos H Karantanas, Andreas Plaitakis, Thomas G Maris.   

Abstract

The dynamic susceptibility contrast magnetic resonance imaging perfusion technique was used to investigate possible hemodynamic changes in normal appearing white matter and deep gray matter (DGM) of 30 patients with clinically isolated syndrome (CIS) and 30 patients with relapsing-remitting multiple sclerosis. Thirty normal volunteers were studied as controls. Cerebral blood volume, cerebral blood flow (CBF), and mean transit time values were estimated. Normalization was achieved for each subject with respect to average values of CBF and mean transit time of the hippocampi's dentate gyrus. Measurements concerned three regions of normal white matter of normal volunteers, normal appearing white matter of CIS and patients with relapsing-remitting multiple sclerosis, and DGM regions, bilaterally. All measured normal appearing white matter and DGM regions of the patients with CIS had significantly higher cerebral blood volume and mean transit time values, while averaged DGM regions had significantly lower CBF values, compared to those of normal volunteers (P < 0.001). Regarding patients with relapsing-remitting multiple sclerosis, all measured normal appearing white matter and DGM regions showed lower CBF values than those of normal volunteers and lower cerebral blood volume and CBF values compared to patients with CIS (P < 0.001). These data provide strong evidence that hemodynamic changes--affecting both white and DGM--may occur even at the earliest stage of multiple sclerosis, with CIS patients being significantly different than relapsing-remitting multiple sclerosis patients.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22367604     DOI: 10.1002/mrm.24194

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  14 in total

1.  Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.

Authors:  G Pontillo; S Cocozza; R Lanzillo; C Russo; M D Stasi; C Paolella; E A Vola; C Criscuolo; P Borrelli; G Palma; E Tedeschi; V B Morra; A Elefante; A Brunetti
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-20       Impact factor: 3.825

Review 2.  Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?

Authors:  Miguel D'haeseleer; Stéphanie Hostenbach; Ilse Peeters; Souraya El Sankari; Guy Nagels; Jacques De Keyser; Marie B D'hooghe
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

3.  Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.

Authors:  Ponnada A Narayana; Yuxiang Zhou; Khader M Hasan; Sushmita Datta; Xiaojun Sun; Jerry S Wolinsky
Journal:  Mult Scler       Date:  2013-07-08       Impact factor: 6.312

Review 4.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

5.  Characterizing the time course of cerebrovascular reactivity in multiple sclerosis.

Authors:  John A Lincoln; Khader M Hasan; Refaat E Gabr; Jerry S Wolinsky
Journal:  J Neuroimaging       Date:  2022-02-14       Impact factor: 2.324

Review 6.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

7.  Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.

Authors:  Stefano Magon; M Mallar Chakravarty; Michael Amann; Katrin Weier; Yvonne Naegelin; Michaela Andelova; Ernst-Wilhelm Radue; Christoph Stippich; Jason P Lerch; Ludwig Kappos; Till Sprenger
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

8.  Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.

Authors:  Maxim Bester; Nils Daniel Forkert; Jan Patrick Stellmann; Klarissa Stürner; Lilian Aly; Anna Drabik; Kim Lea Young; Christoph Heesen; Jens Fiehler; Susanne Siemonsen
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

9.  The role of angiogenesis in the pathology of multiple sclerosis.

Authors:  Justin Lengfeld; Tyler Cutforth; Dritan Agalliu
Journal:  Vasc Cell       Date:  2014-11-28

10.  Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndrome.

Authors:  Efrosini Z Papadaki; Panagiotis G Simos; Vasileios C Mastorodemos; Theodora Panou; Thomas G Maris; Apostolos H Karantanas; Andreas Plaitakis
Journal:  Behav Neurol       Date:  2014-01-23       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.